A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one of the deadliest cancers...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - THEPARADISE.NG - A La Une - 22/Jan 15:30
A novel treatment for oral mucositis
Oral mucositis, a common and painful side effect of cancer treatments, affects 30-40% of patients. It damages rapidly dividing mucosal cells, causing significant discomfort and interfering with vital activities, such as eating and sleeping. Green tea is a natural source of antioxidants, with catechins being its most powerful polyphenols. These antioxidants protect cells from oxidative [...] Read Full Article At: A novel treatment for oral mucositis
Articles similaires
Inhibition of tumor xenograft growth in mice without systemic toxicity
news.medical.net - 27/Mar 06:54
The management of breast cancer involves various therapeutic approaches. However, many current anticancer treatments indiscriminately damage both...
Beyond the Smile: South Africa Must Prioritise Oral Health as a Public Health Imperative
iafrica.com - 25/Mar 15:43
South Africa’s burden of oral diseases is not only inextricably linked to non-communicable diseases but also presents an urgent public health...
Novartis Receives Third FDA Approval for Oral Fabhalta (iptacopan), the First and Only Treatment Approved in C3 Glomerulopathy
drugs.com - 21/Mar 01:03
Basel, March 20, 2025 – Novartis today announced that oral Fabhalta (iptacopan) has received U.S. Food and Drug Administration (FDA) approval...
Novartis Receives Third FDA Approval for Oral Fabhalta (iptacopan), the First and Only Treatment Approved in C3 Glomerulopathy
drugs.com - 21/Mar 01:03
Basel, March 20, 2025 – Novartis today announced that oral Fabhalta (iptacopan) has received U.S. Food and Drug Administration (FDA) approval...
Bioxytran inks non─disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens
pharmabiz.com - 21/Mar 09:36
Bioxytran, Inc, a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, announced the signing of a...
SenePy: Pioneering AI to Track Aging Cells (and) Combat Disease
medindia.net - 26/Mar 21:35
SenePy, an open-source tool that detects aging cells through genetic analysis, helping advance treatments for age-related diseases.
Cedars-Sinai study shows rapid healing of heart damage with cell therapy
news.medical.net - 26/Mar 06:00
A scientific technique that rapidly increases the body's production of anti-inflammatory cells promoted healing from heart attacks in mice, according...
Cedars-Sinai study shows rapid healing of heart damage with cell therapy
news.medical.net - 26/Mar 06:00
A scientific technique that rapidly increases the body's production of anti-inflammatory cells promoted healing from heart attacks in mice, according...
Novel long-acting contraceptive implant can be delivered through tiny needles
news.medical.net - 25/Mar 00:58
Mass General Brigham and MIT investigators have developed a long-acting contraceptive implant that can be delivered through tiny needles to minimize...
Les derniers communiqués
-
Aucun élément